ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

  • Home
  • Favipiravir versus arbidol for COVID-19: a randomized clinical trial

Favipiravir versus arbidol for COVID-19: a randomized clinical trial

27 Apr 2020 5:07 PM | Daniel Hawley (Administrator)


Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software